MSSPT PEPTIDE PEN SKIN GLOW – R 1250

Description 

GHK–Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring tripeptide-copper complex present in human plasma, saliva, and urine. Its chemical structure is Gly–His-Lys-Cu2+, where the tripeptide backbone (glycine-histidine- lysine) coordinates a Cu(II) ion via the histidine imidazole nitrogen, the lysine ε-amino group, and the N-terminal amine. The copper ion is essential for biological activity 

Mechanism of Action 

• GHK–Cu exerts broad regenerative, anti-inflammatory, and tissue-remodeling effects through multiple pathways: Copper delivery to enzymes (lysyl oxidase, superoxide dismutase) enhanced collagen/elastin cross-linking and antioxidant defense Modulation of >4,000 genes (upregulation of repair/remodelling genes; downregulation of pro–inflammatory and matrix- degrading genes) 
• Stimulation of fibroblast proliferation, glycosaminoglycan and proteoglycan synthesis, and angiogenesis (via VEGF and FGF pathways) 
• Suppression of NF-kB and pro-inflammatory cytokines (TNF-a, IL-6) 
• Inhibition of MMPs (matrix metalloproteinases) and stimulation of TIMPS (tissue inhibitors of metalloproteinases) Promotion of keratinocyte migration, wound contraction, and extracellular matrix reorganization 
• These actions collectively accelerate skin repair, improve barrier function, increase dermal thickness/elasticity, reduce inflammation, and counteract photoaging and chronological skin degeneration. 

Indications & Usage 

Skin Glow (GHK-Cu) is used to support skin health, repair, and rejuvenation. It is indicated for: 

• Promotion of collagen and elastin synthesis, skin firmness, and elasticity 
• Acceleration of wound healing and tissue remodelling 
• Reduction of inflammation and oxidative damage in skin 
• Improvement in skin barrier function, hydration, and overall appearance 
• Support for recovery from environmental stress, photoaging, or minor skin trauma 

Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to GHK-Cu, copper, or any excipient 
• Active malignancy or history of copper-related disorders (e.g., Wilson’s disease) 
• Severe uncontrolled inflammatory skin conditions or open wounds at injection sites 
• Pregnancy or breastfeeding 
• Age under 18 years 

 Warnings 

• Use only under medical supervision. 
• Not a substitute for standard dermatological care, sunscreen use, or approved anti-aging therapies. Avoid injection into inflamed, infected, or broken skin. 
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., widespread rash, swelling, breathing difficulty, or signs of copper toxicity). 

Dosage & Administration 

• Subcutaneous injection only. 
• Standard Dose: 5 mg (12 clicks) once daily 
• (1 click≈ 0.417 mg/417 mcg GHK–Cu) 
• Alternative/Higher Dose (if tolerated): Up to 10 mg (24 clicks) daily 
• Frequency: Once daily 
• Timing: Morning, on an empty stomach (wait 30-60 minutes before eating) to optimize absorption 
• Cycle: 20 consecutive days on, followed by 2 weeks off (repeat as needed) 

Administration Instructions

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle. 
3. Dial the required number of clicks (e.g., 12 clicks = 5 mg). 
4. Clean injection site (abdomen or thigh) with alcohol swab. 
5. Insert needle at 45-90° angle and inject slowly. 
6. Withdraw needle, dispose safely, and cap the pen. 
7. Rotate injection sites to minimize irritation. 
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

Side Effects 

GHK–Cu is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including: 

• Mild injection-site irritation, redness, or itching 
• Transient headache or light–headedness 
• Temporary metallic taste or mild nausea 
• Rare skin flushing or changes in energy levels during initial use 
• If any severe or persistent symptoms occur (e.g., widespread rash, swelling, breathing difficulty, or signs of copper overload), discontinue use and contact your healthcare provider immediately. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).
• Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal. 

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN SLUPP – R 1250

Description 

SLU-PP-332 is a first-in-class synthetic small-molecule pan-agonist of estrogen-related receptors (ERRA, ERRẞ, and ERRY). It is a non-steroidal, non-endocrine-disrupting compound belonging to the class of ERR agonists. Chemical name: 4-hydroxy-N-(4-(2-(4-hydroxyphenyl)propan-2-yl)phenyl)benzamide (or structural analog thereof; exact proprietary structure is patented by Saint Louis University). SLU-PP-332 is orally bioavailable, metabolically stable, and designed to selectively activate ERRS without binding classical estrogen receptors (ERa/ERẞ). 

Mechanism of Action 

SLU-PP-332 binds directly to the ligand-binding domain of ERRA, ERRẞ, and ERRY, inducing conformational changes that promote coactivator recruitment (e.g., PGC-1a) and transcriptional activation of ERR target genes. Key downstream effects include: 

• Upregulation of mitochondrial biogenesis and oxidative phosphorylation genes 
• Increased expression of fatty acid oxidation enzymes and mitochondrial uncoupling proteins 
• Enhanced type I (slow-twitch, oxidative) muscle fibre gene programs 
• Improved exercise endurance capacity and metabolic flexibility 
• Activation of energy expenditure pathways independent of classical estrogen signalling 
• The compound induces an “exercise-like” molecular signature in skeletal muscle, liver, adipose tissue, and brain, mimicking many of the metabolic adaptations seen with chronic physical training. 

Indications & Usage 

SLU-PP-332 is used to support mitochondrial function, metabolic health, and exercise-like adaptations. It is indicated for: 

• Enhancement of mitochondrial biogenesis and cellular energy production 
• Promotion of fat oxidation, metabolic efficiency, and insulin sensitivity 
• Support for endurance capacity, muscle oxidative phenotype, and recovery from metabolic stress 
• Assistance in age-related or inactivity-related decline in mitochondrial and metabolic performance 

Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to SLU-PP-332 or any excipient 
• Active malignancy (theoretical concern regarding enhanced cellular metabolism) 
• Severe uncontrolled hepatic or renal impairment 
• Pregnancy or breastfeeding 
• Age under 18 years 

Warnings 

• Use only under medical supervision with periodic monitoring (glucose metabolism, liver function, lipid profile, and clinical parameters). 
• Not a substitute for physical exercise, diet, or approved therapies for metabolic disorders. 
• High doses may cause transient gastrointestinal discomfort, flushing, or changes in energy levels. 
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe abdominal pain, allergic reaction, or unexpected neurological changes). 

Dosage & Administration 

• Subcutaneous injection only. 
• Standard Dose: 1.3 mg per injection (full pen content per dose; typically, 240 clicks = 1.3 mg) 
• Frequency: Once daily or 3-5 times per week (depending on protocol and tolerance) 
• Timing: Morning or pre–activity to maximize energy and metabolic effects 
• Cycle: Typically, 4-12 weeks on, followed by 4 weeks off to maintain efficacy 

Administration Instructions

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle. 
3. Dial the required number of clicks (full dose = 240 clicks for 1.3 mg). 
4. Clean injection site (abdomen or thigh) with alcohol swab. 
5. Insert needle at 45-90° angle and inject slowly. 
6. Withdraw needle, dispose safely, and cap the pen. 
7. Rotate injection sites to minimize irritation. 
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

 Side Effects 

SLU-PP-332 is generally well tolerated in preclinical models. Human data are limited; potential adverse reactions may include: 

• Mild injection-site irritation, redness, or itching 
• Transient headache, light-headedness, or flushing 
• Temporary gastrointestinal discomfort (nausea, bloating) 
• Rare fatigue or changes in energy levels during initial use 
• If any severe or persistent symptoms occur (e.g., severe headache, abdominal pain, or allergic signs), discontinue use and contact your healthcare provider immediately. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C/77-86°F). 
• Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal. 

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN RESA LEA 3 – R 3800

Description 

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of 44 amino acids with a trans-3-hexenoyl group attached to the N-terminal tyrosine. Chemical name: trans-3-hexenoyl-Tyr–Ala-Asp-Ala-Ile-Phe- Thr–Asn–Ser–Tyr-Arg–Lys-Val-Leu-Ala-Gln–Leu–Ser–Ala–Arg–Lys-Leu-Leu-Gln-Asp-lle-Met-Ser–Arg–Gln–Gln-Gly-Glu-Ser- Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2. Molecular weight ≈5135 Da. It is a stabilized GHRH(1-44) analog designed to resist enzymatic degradation (particularly by dipeptidyl peptidase IV) while retaining full biological activity at the pituitary GHRH receptor.

Mechanism of Action 

Tesamorelin binds with high affinity to the GHRH receptor on somatotroph cells in the anterior pituitary, stimulating pulsatile secretion of endogenous growth hormone (GH). This leads to:

• Increased circulating IGF-1 levels
• Enhanced lipolysis in visceral adipose tissue (via hormone–sensitive lipase activation)
• Reduced hepatic triglyceride synthesis and VLDL secretion
• Improved lipid profile (decreased triglycerides, increased HDL)
• Mild anabolic effects on lean tissue without significant impact on glucose homeostasis at therapeutic doses

Unlike exogenous recombinant GH, Tesamorelin preserves physiological pulsatile GH secretion and feedback regulation via IGF–1.

Indications & Usage 

Tesa Lea3 (Tesamorelin) is used to support reduction of visceral adipose tissue and improvement in metabolic parameters. It is indicated for:

• Reduction of excess abdominal fat accumulation
• Support for body composition optimization (decrease in visceral fat while preserving lean mass)
• Assistance in metabolic health during age–related or treatment–associated fat redistribution
• General support for lipid profile and visceral fat–related wellness

Contraindications & Warnings 

Do not use if you have:

• • Known hypersensitivity to tesamorelin, mannitol, or any excipient
  • Active malignancy or history of cancer (active neoplastic disease)
  • Pregnancy or breastfeeding
  • Children or adolescents (not indicated)
  • Severe hepatic impairment (Child-Pugh C)

• Known pituitary tumour or intracranial lesion

Warnings 

• Use only under medical supervision with regular monitoring (IGF-1, glucose, lipids, and clinical parameters).
• Increased risk of glucose intolerance, new-onset diabetes, or worsening of pre–existing diabetes.
• Potential for fluid retention, arthralgia, myalgia, or carpal tunnel syndrome (usually transient). Rare risk of intracranial hypertension or hypersensitivity reactions.
• Not a substitute for lifestyle interventions or approved therapies for metabolic disorders.
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe headache with visual changes, severe abdominal pain, or signs of allergic reaction).

Dosage & Administration 

• Frequency: Once daily.
• Timing: Preferably at bedtime on an empty stomach or as directed by your healthcare provider.

Administration Instructions

1. Wash hands and prepare a clean surface.
2. Attach a sterile needle.
3. Dial the required number of clicks.
4. Clean injection site (abdomen) with alcohol swab
5. Insert needle at 45-90° angle and inject slowly.
6. Withdraw needle, dispose safely, and cap the pen.
7. Rotate injection sites (abdomen) daily to minimize irritation.
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects 

Tesamorelin is generally well tolerated at therapeutic doses. Common or potential adverse reactions include:

• Injection-site reactions (erythema, pain, pruritus, swelling, hematoma)
• Peripheral edema or fluid retention
• Arthralgia, myalgia, or musculoskeletal stiffness
• Headache
• Glucose intolerance or hyperglycaemia
• Hypersensitivity reactions (rash, urticaria; rare anaphylaxis)
• Rare: Carpal tunnel syndrome, elevated liver enzymes, or gynecomastia
• Most reactions are mild to moderate and decrease over time.
• If severe or persistent symptoms occur, discontinue use and contact your healthcare provider immediately.

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C/77-86°F).
• Keep pen capped and protected from light and heat.
• After first use: Same storage conditions.
• Keep out of reach of children.
• Discard if expired or solution appears abnormal.

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN NIGHT SURGE – R 1500

Description 

Night Surge combines two synergistic growth hormone secretagogues:

CJC-1295 (No DAC): A synthetic tetrasubstituted analog of growth hormone-releasing hormone (GHRH) designed to stimulate the natural release of growth hormone from the pituitary gland. The peptide contains four amino acid substitutions that enhance stability and resistance to enzymatic degradation while maintaining its ability to bind to GHRH receptors. Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂.

Ipamorelin: A selective pentapeptide ghrelin mimetic and growth hormone secretagogue that stimulates growth hormone release while minimizing effects on cortisol and prolactin. Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (Aib = 2-aminoisobutyric acid).

Mechanism of Action 

• CJC–1295 binds to GHRH receptors on pituitary somatotrophs, stimulating prolonged, pulsatile release of endogenous growth hormone (GH) while preserving physiological feedback regulation. The DAC modification extends its half-life to several days, allowing sustained GH pulses. 
• Ipamorelin acts as a ghrelin receptor (GHSR-1a) agonist, triggering acute GH release via the pituitary without significant effects on cortisol, prolactin, ACTH, or appetite. 

The combination produces additive or synergistic GH pulses: CJC-1295 provides sustained baseline elevation, while Ipamorelin generates sharp nocturnal peaks. This mimics youthful GH secretion patterns, promoting nocturnal tissue repair, protein synthesis, lipolysis, and recovery during sleep. 

Indications & Usage 

Night Surge is used to support physiological growth hormone release and nocturnal recovery. It is indicated for: 

• Enhancement of deep restorative sleep and sleep–associated tissue repair 
• Promotion of muscle recovery, protein synthesis, and connective tissue remodelling 
• Support for fat metabolism and body composition during rest 
• Assistance in age–related decline of natural GH secretion and recovery capacity 

Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to CJC-1295, Ipamorelin, or any excipient 
• Active malignancy or history of cancer (GH/IGF-1 axis stimulation concern) 
• Severe uncontrolled diabetes mellitus or proliferative diabetic retinopathy 
• Intracranial lesion or pituitary tumor 
• Pregnancy or breastfeeding 
• Age under 18 years 

Warnings 

• Use only under medical supervision with periodic monitoring (IGF-1, glucose, HbA1c, clinical parameters). 
• Not a substitute for standard medical treatment of sleep disorders, metabolic conditions, or recovery needs. 
• Potential for glucose intolerance, fluid retention, or carpal tunnel symptoms (usually transient). 
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe headache with visual changes, severe abdominal pain, or signs of allergic reaction). 

Dosage & Administration 

• Subcutaneous injection only. 
• Standard Dose Range: 400-500 mcg total blend per injection (~200-250 mcg each peptide) 
  • 400 mcg total≈ 10 clicks 
  • 500 mcg total≈ 12 clicks 
• Frequency: Once daily, 5-7 nights per week (e.g., 5 on/2 off for recovery protocols) 
• Timing: Evening/bedtime (ideally 1-2 hours after last meal, on empty stomach) to align with natural nocturnal GH surge 
• Cycle Length: 8-16 weeks on (often 12 weeks for sustained protocols), followed by 4 weeks off to maintain pituitary sensitivity 

Administration Instructions

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle. 
3. Dial the required number of clicks. 
4. Clean injection site (abdomen or thigh) with alcohol swab. 
5. Insert needle at 45-90° angle and inject slowly. 
6. Withdraw needle, dispose safely, and cap the pen. 
7. Rotate injection sites to minimize irritation. 
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

Side Effects 

The combination is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including: 

• Mild injection-site irritation, redness, or itching 
• Transient headache, light-headedness, or flushing 
• Temporary water retention or joint stiffness (dose–related) 
• Rare mild gastrointestinal discomfort or changes in appetite 
• Rare transient elevation in blood glucose or insulin resistance markers 
• If any severe or persistent symptoms occur (e.g., severe headache with visual changes, severe abdominal pain, or allergic signs), discontinue use and contact your healthcare provider immediately. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal. 

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN NMN – R 1400

Description 

Nicotinamide Mononucleotide (NMN) is a nucleotide derived from ribose, nicotinamide, nicotinamide riboside, and niacin (vitamin B3). Its chemical structure is C,,H15N2OP, consisting of a nicotinamide moiety linked to a ribose sugar phosphorylated at the 5‘ position. NMN is the direct precursor to nicotinamide adenine dinucleotide (NAD), a critical coenzyme found in every cell. 

Mechanism of Action 

NMN is rapidly taken up by cells via the Slc12a8 transporter (in small intestine and other tissues) and converted to NAD* through the salvage pathway, primarily by nicotinamide mononucleotide adenylyl transferases (NMNAT1-3). Elevated NAD* levels activate key NAD+-dependent enzymes: 

• Sirtuins (SIRT1-7) epigenetic regulation, DNA repair, mitochondrial biogenesis, inflammation control, and longevity pathways 
• PARPS → DNA damage repair and genomic stability 
• CD38/CD157 → calcium signalling and immune modulation 

The net result is enhanced mitochondrial function, increased energy production (ATP), improved metabolic flexibility, reduced oxidative stress, better insulin sensitivity, and activation of cellular repair and anti aging mechanisms. 

Indications & Usage 

NMN is used to support cellular energy metabolism, mitochondrial health, and age–related physiological processes. It is indicated for: 

• Promotion of NAD+ levels and cellular energy production 
• Support for mitochondrial function, metabolic efficiency, and insulin sensitivity
• Assistance during age-related decline in vitality, endurance, and recovery capacity 
• General support for healthy aging, cognitive resilience, and physical performance 

Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to NMN or any excipient 
• Active malignancy (theoretical concern regarding enhanced cellular metabolism) Severe uncontrolled liver or kidney disease 
• Pregnancy or breastfeeding 
• Age under 18 years 

Warnings 

• Use only under medical supervision with periodic monitoring (liver function, glucose metabolism, and clinical parameters). 
• Not a substitute for lifestyle interventions or approved therapies for metabolic or age–related conditions. 
• High doses may cause transient flushing or gastrointestinal discomfort. 
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe abdominal pain, allergic reaction, or unexpected neurological changes). 

Dosage & Administration 

• Subcutaneous injection only. 
• Daily Wellness / Longevity: 3-4 clicks daily in the morning (18.75-25 mg NMN)
• Therapeutic/Mitochondrial Support: 8-12 clicks daily, 5x per week (50-75 mg NMN) 
• High Performance / Anti-Aging Protocol: 20 clicks (125 mg NMN) three times per week for 4-6 weeks 
• Frequency: As per protocol (daily for wellness/therapeutic; 3x/week for high performance)
• Timing: Morning (preferred for energy and NAD* support) or as directed by your healthcare provider 

Administration Instructions

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle. 
3. Dial the required number of clicks. 
4. Clean injection site (abdomen or thigh) with alcohol swab. 
5. Insert needle at 45-90° angle and inject slowly. 
6. Withdraw needle, dispose safely, and cap the pen. 
7. Rotate injection sites to minimize irritation. 
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

Side Effects 

NMN is generally well tolerated across studied doses. Reported reactions are uncommon and usually mild/transient, including: 

• Mild injection–site irritation, redness, or itching 
• Transient headache, light-headedness, or flushing 
• Temporary gastrointestinal discomfort (nausea, bloating) 
• Rare fatigue or changes in energy levels during initial use 
• If any severe or persistent symptoms occur (e.g., severe headache, abdominal pain, or allergic signs), discontinue use and contact your healthcare provider immediately. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal. 

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT ANTI-C PEPTITE PEN – R 1800

PNC-27 is a synthetic 32-amino-acid peptide conjugate consisting of the HDM-2-binding domain of p53 (residues 12- 26) fused to the membrane–active portion of the membrane–lytic peptide HDM-2 (residues 17-45) from human cytochrome b562. Chemical Structure:

PNC-27 sequence: H-M-P-F-K-E-T-K-L-L-D-E-L-E-E-I-T-E-L-E-K-L-L-E-E-V-A-K–M-Y-K-E-L-E-K-L-G-S-G-S-G-K-K-K-K-K-K- K-K-K-K-K-K–K–K-K-K-OH The N-terminal p53 domain binds with high affinity to HDM-2 (murine double minute 2, the negative regulator of p53), while the C-terminal poly-lysine segment confers amphipathic a-helical structure and membrane-disrupting activity.

Mechanism of Action

PNC-27 selectively targets cancer cells that overexpress HDM-2 on their surface (a common feature in many solid tumors and leukaemia’s). Binding of the p53 domain to surface HDM- 2 anchors the peptide, allowing the amphipathic C-terminal segment to insert into the cell membrane, forming pores. This induces rapid membrane permeabilization, leakage of intracellular contents, and necrotic cell death specifically in cancer cells. Normal cells express little to no surface HDM-2 and are spared. The peptide does not rely on intracellular p53 pathways, making it potentially effective in p53-mutated or -deleted cancers.

Indications & Usage

Anti-Cancer (PNC-27) is used to support targeted elimination of cancer cells expressing surface HDM-2. It is indicated for investigational use in:

Solid tumors and hematologic malignancies with documented surface HDM-2 overexpression Support for reduction of tumor burden in selected cancer types

Assistance in experimental protocols aimed at selective cancer cell necrosis

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to PNC-27 or any excipient

Active bleeding disorders or severe thrombocytopenia Uncontrolled infection or sepsis

Pregnancy or breastfeeding

Age under 18 years

Warnings

Use only under strict medical supervision in a clinical or research setting.

Not approved for standard cancer treatment, experimental use only.

Potential for rapid tumor lysis syndrome in patients with high tumor burden.

Monitor closely for signs of systemic inflammatory response, electrolyte disturbances, or renal impairment.

Discontinue immediately and seek emergency medical attention if severe symptoms occur (e.g., high fever, rapid swelling, breathing difficulty, or signs of tumor lysis syndrome).

Dosage & Administration

Subcutaneous injection only (intravenous use has been reported in some protocols but is not standard for this pen formulation).

Standard Investigational Dose: 0.5-1 mg per injection (common range in early studies) 0.5 mg≈ 6 clicks

1 mg 12 clicks

Frequency: Once daily or as directed by your supervising physician/research protocol Timing: Consistent daily timing (morning or evening)

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial the required number of clicks.

Clean injection site (abdomen or thigh) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

PNC-27 is experimental; human safety data are limited. Reported or potential adverse reactions include:

Injection-site reactions (pain, redness, swelling, induration)

Flu-like symptoms (fever, chills, fatigue, myalgia)

Transient elevation of inflammatory markers or liver enzymes

Rare tumor lysis syndrome (hyperuricemia, hyperkalaemia, acute kidney injury) in high-burden disease

Rare systemic inflammatory response or cytokine release-like symptoms

If any severe or unexpected symptoms occur (e.g., high fever, rapid swelling, breathing difficulty, or signs of tumor lysis), discontinue use and seek immediate medical attention.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C/77-86°F).

Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance-providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN NERVE REPAIR – R 1650

Description
ARA-290 (Cibinetide) is a synthetic 11-amino-acid peptide derived from erythropoietin (EPO). It selectively activates the innate repair receptor (IRR) without stimulating red blood cell production. Chemical Structure
Sequence: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (pyroglutamate at N-terminus).Mechanism of Action
ARA-290 binds to the tissue-protective IRR complex (EPOR + βcR), triggering potent anti-inflammatory, anti-apoptotic, and regenerative signalling in nerves and other tissues. It promotes:

• Axonal repair, remyelination, and nerve regeneration
• Reduction of neuropathic pain and neuroinflammation
• Improvement of microvascular function and tissue oxygenation
• Activation of protective pathways (JAK2/STAT3, PI3K/Akt) while avoiding hematopoietic effects

Indications & Usage
Nerve Repair (ARA-290 / Cibinetide) is used to support nerve regeneration and neuropathic recovery. It is indicated for:

• Promotion of peripheral nerve repair and regeneration
• Reduction of neuropathic pain and neuroinflammation
• Support for recovery from nerve injury, compression, diabetic neuropathy, or post-surgical nerve damage
• Assistance in tissue protection and functional recovery

Contraindications & Warnings
Do not use if you have:

• Known hypersensitivity to ARA-290 or any excipient
• Active malignancy or history of cancer
• Severe uncontrolled cardiovascular disease
• Pregnancy or breastfeeding
• Age under 18 years

Warnings

• Use only under medical supervision with appropriate monitoring.
• Not a substitute for standard medical or surgical treatment of neuropathy or nerve injury.
• Monitor for changes in pain levels or neurological function.
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., worsening neurological deficits or allergic reaction).

Dosage & Administration

• Subcutaneous injection only.
• Standard Dose: 2–4 mg (10–19 clicks) per injection (common research range scaled for 50 mg pen)
• Frequency: Once daily or every other day
• Timing: Consistent daily timing (evening preferred for nerve recovery)
• Cycle: Typically 4–8 weeks on, followed by 2–4 weeks off

Administration Instructions:

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle.
3. Dial your dose (e.g., 12 clicks ≈ 2.5 mg).
4. Clean injection site (abdomen or thigh) with alcohol swab.
5. Insert needle at 45–90° angle and inject slowly.
6. Withdraw needle, dispose safely, and cap the pen.
7. Rotate injection sites to minimize irritation.
8. Always inspect solution: Do not inject if cloudy, discoloured, or containing particles.

Side Effects
ARA-290 is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

• Mild injection-site irritation, redness, or itching
• Transient headache or light-headedness
• Temporary changes in energy levels or mild fatigue
• Rare mild gastrointestinal discomfort

If any severe or persistent symptoms occur (e.g., worsening pain, neurological changes, or allergic signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25–30°C / 77–86°F).
• Keep pen capped and protected from light and heat.
• After first use: Same storage conditions.
• Keep out of reach of children.
• Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector—delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance—providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN 5 AMINI-1MQ                   PEN – R 1200

5-Amino-1MQ is a synthetic small-molecule compound with the chemical name 5-amino-1-methylquinolinium (also known as 5-amino-1-methylquinolin-1-ium). It is a positively charged heterocyclic molecule structurally related to quinolinium derivatives. Mechanism of Action

5-Amino-1MQ acts as a potent and selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme highly expressed in adipose tissue, liver, and certain metabolically active cells. NNMT catalyses the transfer of a methyl group from S–adenosylmethionine (SAM) to nicotinamide, producing 1–methylnicotinamide and S–adenosylhomocysteine (SAH). By inhibiting NNMT, 5-Amino-1MQ:

Reduces 1-methylnicotinamide production

Preserves intracellular nicotinamide levels

Increases NAD+ availability

Shifts cellular metabolism toward oxidative pathways

Enhances mitochondrial function and energy expenditure

Decreases fat storage and adipocyte differentiation

These effects support improved metabolic efficiency, reduced adipose tissue accumulation, and preservation of lean mass.

Indications & Usage

5–Amino-1MQ is used to support metabolic health and body composition. It is indicated for:

Promotion of fat metabolism and oxidation

Preservation of lean muscle mass during weight management

Support for energy expenditure and metabolic efficiency

Assistance in cellular energy homeostasis and anti-aging metabolic pathways

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to 5-Amino-1MQ or any excipient

Severe uncontrolled hypertension or cardiac arrhythmias

Active malignancy or history of hormone-dependent cancer

Severe hepatic or renal impairment

Age under 18 years

Pregnancy or breastfeeding

Warnings

Use only under medical supervision.

Monitor blood pressure, heart rate, and metabolic parameters during use.

Not a substitute for diet, exercise, or approved medical therapies for obesity or metabolic disorders. Discontinue immediately and seek medical attention if severe symptoms occur (e.g., rapid heartbeat, chest pain, severe headache, or signs of allergic reaction).

Dosage & Administration

Subcutaneous injection only.

Standard Dose: 5 mg (12 clicks) once daily

(1 click≈ 0.417 mg/417 mcg)

Alternative / Higher Dose (if tolerated): Up to 10 mg (24 clicks) daily

Frequency: Once daily

Timing: Morning, on an empty stomach (wait 30-60 minutes before eating) to optimize metabolic effects Cycle: 20 consecutive days on, followed by 2 weeks off (repeat as needed)

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial the required number of clicks (e.g., 12 clicks = 5 mg).

Clean injection site (abdomen or thigh) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

5–Amino-1MQ is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching

Transient headache or light-headedness

Temporary changes in energy levels or appetite

Rare mild gastrointestinal discomfort

If any severe or persistent symptoms occur (e.g., rapid heartbeat, severe headache, or signs of allergic reaction), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN SHREDDED – R 1550

Dosage/Administration Protocol: 

Each click delivers≈ 0.01083 ml (2.6 ml ÷ 240), equating to roughly 0.0417 mg (41.7 mcg) total blend per click (~20.85 mcg AOD-9604+ 12.5 mcg Tesamorelin + 8.33 mcg MOTS-c per click, based on ratios).

• Recommended Protocol for Fat Loss/Performance Use Consensus from recent blend protocols Favors once-daily morning fasted SubQ dosing in the 300-500 mcg total blend range (delivering proportional amounts of each peptide; aligns with AOD/Tesamorelin/MOTS-C stacks for metabolic synergy without high GH sides).
• Standard dose per injection: 333-417 mcg total blend (common effective “sweet spot” for daily fat-burning support; e.g., ~333 mcg provides scaled ~167 mcg AOD + 100 mcg Tesamorelin + 67 mcg MOTS-c).333 mcg total (~8 clicks; matches some pen-specific “Shredded” guides for ~30 doses/pen): ≈ 8 clicks (333 ÷ 41.7~ 8).
• 417 mcg total (~10 clicks; closer to 400 mcg blends):≈ 10 clicks (417÷ 41.7≈ 10).
• Frequency: Once daily (some use 5-6 days/week with 1-2 off for long-term tolerance).
• Timing: Morning fasted (on empty stomach; wait 30-60 minutes before eating to optimize lipolysis/insulin dynamics). Titration example (start low for tolerance-monitor energy, any mild irritation, water retention, or glucose changes): Weeks 1-4: 333 mcg total (8 clicks) daily.
• Weeks 5+: Increase to 417 mcg total (10 clicks) daily if tolerated and progress desired.
• Cycle length: 8-12 weeks on (extend to 12-16 weeks in some protocols for sustained fat loss), followed by 4-6 weeks off.
• Number of doses per pen: At 333 mcg total (8 clicks):≈ 30 doses (240 ÷ 8 = 30).
• At 417 mcg total (10 clicks): ≈ 24 doses (240 ÷ 10 = 24).
• Alternative higher dose (advanced, once tolerance built): 500 mcg total≈ 12 clicks (500 ÷ 41.7≈ 12; scaled ~250 mcg AOD + 150 mcg Tesamorelin + 100 mcg MOTS-c), but use cautiously (e.g., 5 days on/2 off).

Storage Instructions

How to Store Your Peptide Pen Your pre-filled Peptide Pen is formulated with preservatives for enhanced stability, allowing storage in a cool, dry place at controlled room temperature (do not exceed 25-30°C/77-86°F)

• Store in a cool, dry place. No refrigeration needed.
• Protect from light and heat. .
• Avoid exposure to direct sunlight, extreme heat, humidity (e.g., do not store in bathrooms), or freezing temperatures.
• Keep the pen in its original carton or packaging to shield it from light until first use.
• After first use, continue storing in the same conditions and follow the usage timeline provided (e.g., discard after X days/weeks if applicable check specific product details).
• Always inspect the solution for clarity/particles before use; do not use if it appears cloudy, discoloured, or contains visible particles.
• Keep out of reach of children and pets.

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.